Social Media in the Pharmaceutical Industry
Date: 22nd – 23rd January 2018
Workshop: 24th January 2018
Location: Holiday Inn London - Kensington Forum
97 Cromwell Rd, Kensington, London SW7 4DN, UK
About Social Media in the Pharmaceutical Industry
SMi Group are delighted to present the return of their 10th Annual Social Media in the Pharmaceutical Industry conference to London on the 23rd – 24th January 2018. www.social-media-pharma.com/cserv
Social media is the perfect channel for pharmaceutical companies to educate, market, listen and connect with customers, patients and physicians. How the pharmaceutical industry utilize social media is particularly complex as regulators such as the FDA have not yet written the rules about how pharmaceuticals can engage with potential customers and patients.
Join SMi’s 10th Annual Social Media in the Pharmaceutical Industry Conference to learn the best way your company can benefit from social media. Hear from industry experts on how to leverage social media platforms to develop a robust digital strategy and discuss the latest challenges and techniques in the field of ‘social pharma’.
How Will You Benefit?
Network and learn from leading professionals such as:
- Emma Sutcliffe, Director, Patient Engagement & Innovation, NexGen Healthcare
- Tughan Demirbilek, Strategy & Operations Director, Bristol-Myers Squibb
- Marcel Gmünder, Global Head, Digital Health Group, Roche Diabetes Care
- Elodie Douangmanivanh, Head of Digital Services, MSD
- Sebastian Soithongsuk, Global Content Manager Digital Comms, GSK
- Aslihan Unal, Digital Strategy Group Manager, Janssen
- Hervé Dumas, Patients’ Technology Solutions Lead, UCB
- Sarah Holiday, Social Media Strategy Lead, Pfizer
Some Featured Highlights will include:
- Hear how Janssen create powerful pharmaceutical social media strategies enabling patient engagement.
- Learn how to build integrated, impactful social media strategies with Pfizer.
- Discuss the potential of wearable technologies creating behavioural changes for patients with UCB.
- Discover with GSK how to make your social media content less “promotional” and more about storytelling.
- Examine how Bristol Myers-Squibb create an excellent digital strategy whilst engaging patients.
View the full agenda: www.social-media-pharma.com/crtn
• BOOK BY 30TH NOVEMBER AND SAVE £100
Social Media Handles:
Event Hashtag: #pharmasocialmedia
The course is designed to provide students with a broad and comprehensive understanding of issues related to the development and regulation of drugs, biologics, vaccines, devices, and in vitro diagnostics. Lectures focus on basic drug development topics - such as translational medicine, clinical pharmacology, epidemiology, drug regulation, and adverse drug event reporting - as well as broader - such as pharmacoeconomics, drug-device combinations, biosimilars, working with investigative sites, and drug marketing.
Educational Objectives for CME - at the conclusion of the activity, participants will be able to:
Clinical Pharmacology: Integrate the relevant pharmacology, pharmacokinetics, and statistics related to drug development and the nature of evidence required for proof of efficacy and safety.
Drug Development and Clinical Trials: Using a case-study approach, identify and solve practical, theoretical, and technical problems in human drug studies, and analyze an experimental design for a new drug candidate.
Regulation: Evaluate the science, laws, and regulations pertaining to the development and review of new drug products in the USA, Europe, Japan and other pharmaceutical markets.
*Groups of 3 or more receive discounted rates.
Some notable areas of increased attention have been the broader trends for combination products and biologics, as well as the move towards digital health and improving patient adherence due to increased self-administration figures. As well as these areas of lucrative opportunity, there are still several ongoing challenges that the key-thought leaders are battling to overcome. these include the challenges of chemical compatibility, user safety, high-volume and highly viscous formulation, and non-compliance. Pre-Filled Syringes East Coast will once again play host to an international audience to discuss emerging trends and offer innovative solutions to the challenges facing the prefilled industry, helping attendees to secure global success for their PFS device. Our notable panel of industry leading experts will include senior representatives and decision makers from the likes of Shire, Scynexis, Janssen Pharmaceuticals, Eli Lilly, Takeda, Sanofi, Teva, Medimmune, Shire, GlaxoSmithKline and Merck.
For the forthcoming conference, we will be continuing with debates as well as adhering to the format of the previous conferences which are designed to provide an in-depth progress report on new antiepileptic drugs in various stages of development, as well as to present new findings on second-generation treatments.
Conference-Service.com offers, as part of its business activities, a directory of upcoming scientific and technical meetings. The calendar is published for the convenience of conference participants and we strive to support conference organisers who need to publish their upcoming events. Although great care is being taken to ensure the correctness of all entries, we cannot accept any liability that may arise from the presence, absence or incorrectness of any particular information on this website. Always check with the meeting organiser before making arrangements to participate in an event!